DRKS00013340已完成未知

Effect of a transcutaneous vagusnerve Stimulation of the ear on the muscle activity in the gastrointestinal tract as a potential therapeutic target to prevent postoperative Ileus (transVaGa) - transVaGa

Klinik und Poliklinik für Allgemein-, Viszeral-, Thorax- und GefäßchirurgieUniversitätsklinikum Bonn0 个研究点目标入组 14 人开始时间: 2017年11月28日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•Patients who are at least18 years old and younger than 70 years old
•-written informed consent
•- Patients who undergo an elective, abdominal surgery with open laparotomy during colon-,small bowel-, gastric- oesophagus- or pancreas-resection.
•-Patients, who are able to understand and follow the study protocol (comliance)
•-negative pregnancy test (ß-HCG serum testing), if female patients don´t have a status after hysterectomy.

•General exclusion criteria
•-Age:<18 and >70 years
•- patients who are not willing to participate
•- patients, who are not able to understand the study and are not compliant
•- patients who participate in another clinical trial at the same time or up to 30 days before the clinical Trial.
•- Patient with an active implants (a.e. Cochlea-implant, vagusnerv-stimulator, Defibrillator)
•- active drug abuse
•- positive pregnancy or nursing period
•Specific exclusion criteria:
•- Gastritis
•- stomach ulcer
•- gastroparese
•- Status after gastrectomy
•- diabetes
•- neuropthological diseases
•- emergency surgery
•- increased bleeding tendency
•- intake of anticholinergic drugs
•- patients with uncontrolled, severe diseases, a.e. instable heart condition, parkinson´s disease, hepatic or renal failure.

发起方

Klinik und Poliklinik für Allgemein-, Viszeral-, Thorax- und GefäßchirurgieUniversitätsklinikum Bonn